Literature DB >> 15848661

Living donor liver transplantation for hepatocellular carcinoma: a special reference to a preoperative des-gamma-carboxy prothrombin value.

M Shimada1, Y Yonemura, H Ijichi, N Harada, S Shiotani, M Ninomiya, T Terashi, T Yoshizumi, Y Soejima, Y Maehara.   

Abstract

BACKGROUND: Des-gamma-carboxy prothrombin (DCP) is a sensitive marker related to vascular invasion of hepatocellular carcinoma (HCC). The aim of this study was to clarify the risk factors of HCC recurrence in living donor liver transplantation (LDLT) with special reference to preoperative DCP values.
METHODS: Forty consecutive adult HCC patients who underwent LDLT were examined for a correlation between the DCP value and vascular invasion. Risk factors for recurrence were also investigated using clinicopathological variables including preoperative DCP levels.
RESULTS: The incidence of positive histological vascular invasion in patients with DCP values above 300 mAU/mL was higher than that with those with DCP value below 300 mAU/mL. Other significant risk factors for recurrence were over 5 cm tumor diameter, not meeting the Milan criteria, AFP value >400 ng/mL, histological vascular invasion, poorly differentiated histology, and male gender. Among the patients who did not meet the Milan criteria, those with both no more than 5 cm of tumor diameter and no more than 300 mAU/mL DCP exhibited a good prognosis.
CONCLUSIONS: A high DCP value, namely >300 mAU/mL correlated with histological vascular invasion and was one of the strongest prognostic variables. Therefore, special attention should be paid to HCC patients with high DCP values. No correlation between the number of tumor nodules and recurrence was found; therefore, the Milan criteria may require revision regarding the number of tumor nodules.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15848661     DOI: 10.1016/j.transproceed.2004.12.030

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  8 in total

1.  Phenotype-dependent production of des-γ-carboxy prothrombin in hepatocellular carcinoma.

Authors:  Hideto Suzuki; Kazumoto Murata; Takaya Gotoh; Masao Kusano; Hiroshi Okano; Takashi Oyamada; Yoshikazu Yasuda; Masatoshi Imamura; Masatoshi Kudo; Masashi Mizokami; Atsushi Sakamoto
Journal:  J Gastroenterol       Date:  2011-07-09       Impact factor: 7.527

Review 2.  Role of organ transplantation in the treatment of malignancies: hepatocellular carcinoma as the most common tumour treated with transplantation.

Authors:  Gyula Végso; Dénes Görög; Imre Fehérvári; Balázs Nemes; Attila Doros; Róbert Miklós Langer; László Kóbori
Journal:  Pathol Oncol Res       Date:  2011-09-07       Impact factor: 3.201

3.  Gadoxetic acid-enhanced MRI as a predictor of recurrence of HCC after liver transplantation.

Authors:  Sunyoung Lee; Kyoung Won Kim; Woo Kyoung Jeong; Myeong-Jin Kim; Gi Hong Choi; Jin Sub Choi; Gi-Won Song; Sung-Gyu Lee
Journal:  Eur Radiol       Date:  2019-08-30       Impact factor: 5.315

4.  Des-gamma-carboxy prothrombin as an important prognostic indicator in patients with small hepatocellular carcinoma.

Authors:  Kenichi Hakamada; Norihisa Kimura; Takuya Miura; Hajime Morohashi; Keinosuke Ishido; Masaki Nara; Yoshikazu Toyoki; Shunji Narumi; Mutsuo Sasaki
Journal:  World J Gastroenterol       Date:  2008-03-07       Impact factor: 5.742

5.  Protein induced by vitamin K absence or antagonist-II production is a strong predictive marker for extrahepatic metastases in early hepatocellular carcinoma: a prospective evaluation.

Authors:  Hyun-Mi Bae; Jeong-Hoon Lee; Jung-Hwan Yoon; Yoon Jun Kim; Dae Seog Heo; Hyo-Suk Lee
Journal:  BMC Cancer       Date:  2011-10-10       Impact factor: 4.430

6.  Frequency of and predictive factors for vascular invasion after radiofrequency ablation for hepatocellular carcinoma.

Authors:  Yoshinari Asaoka; Ryosuke Tateishi; Ryo Nakagomi; Mayuko Kondo; Naoto Fujiwara; Tatsuya Minami; Masaya Sato; Koji Uchino; Kenichiro Enooku; Hayato Nakagawa; Yuji Kondo; Shuichiro Shiina; Haruhiko Yoshida; Kazuhiko Koike
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

Review 7.  A Surgical Perspective on Targeted Therapy of Hepatocellular Carcinoma.

Authors:  Claire Faltermeier; Ronald W Busuttil; Ali Zarrinpar
Journal:  Diseases       Date:  2015-09-29

8.  Prediction of vascular invasion in hepatocellular carcinoma by next-generation des-r-carboxy prothrombin.

Authors:  Tomoharu Kurokawa; Shintaro Yamazaki; Yusuke Mitsuka; Masamichi Moriguchi; Masahiko Sugitani; Tadatoshi Takayama
Journal:  Br J Cancer       Date:  2015-12-17       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.